AzTrials
AzTrials

Neurological DisordersAURORANCT07865546

Advanced Space-time Resolved Techniques for Functional Neuroimaging at 7 Tesla MRI

A study testing Functional neuroimaging in people with Neurological Disorders and Neuroscience, run by Imago 7 Fondazione di Ricerca onlus at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In recent years, the in vivo study of the central nervous system has undergone significant advancement through the implementation of magnetic resonance imaging (MRI)-based neuroimaging techniques. Read more about this study

Who is it for?
Ages 6 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Neurological Disorders, Neuroscience, Epilepsy
What is being tested?
Functional neuroimaging
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteItaly
Study dates
16 Oct 2024to 16 Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Age ≥ 18 years;
  • No history of diagnosed psychiatric disorders;
  • Sufficient understanding of the Italian language (required both for informed consent and for comprehension of fMRI task instructions);
  • Provision of written informed consent.
  • Patients
  • Age 6-65 years;
Show all 10Show fewer
  • Diagnosis of drug-resistant epilepsy (PMID: 19889013), with or without structural brain abnormalities, and candidate for surgical treatment (PMID: 21145290, 24497269, 31876960), or presence of pre-, peri-, or post-natal brain lesions documented by prior brain MRI;
  • Normal intellectual functioning or mild cognitive impairment sufficient to ensure adequate collaboration during the 7T functional neuroimaging study;
  • Sufficient understanding of the Italian language (required both for informed consent and comprehension of fMRI task instructions);
  • Provision of written informed consent (and assent when applicable, according to age and regulations).

Who cannot join

  • Contraindications to 7T MRI;
  • Neuropsychiatric comorbidities preventing adequate collaboration during functional neuroimaging;
  • Pregnancy;
  • Refusal to receive information regarding incidental findings identified during MRI examination.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site, 1 recruiting
  • Imago7 Foundation

    Pisa, Italy, 56128

    Renzo Guerrini, Professor

    Recruiting

Other trials in Italy

About this study

Official title: Advanced Space-time Resolved Techniques for fUnctional neuROimaging Characterization of Structurally Abnormal Eloquent coRtical Areas

In recent years, the in vivo study of the central nervous system has undergone significant advancement through the implementation of magnetic resonance imaging (MRI)-based neuroimaging techniques. In particular, the advent of high- and ultra-high-field MRI systems has substantially contributed to a deeper understanding of the pathophysiological mechanisms underlying neurological diseases and has supported the development of personalized approaches in medicine. In the field of neuroimaging, the application of MRI techniques to investigate brain function and connectivity in vivo is increasingly expanding at ultra-high magnetic field strength (7T).

This research project aims to develop, implement, and optimize advanced techniques to improve image quality through deep learning-based approaches and real-time monitoring of magnetic field fluctuations, with the goal of achieving functional neuroimaging at very high spatial and temporal resolution on a 7T scanner.

Read more

These techniques will be applied in healthy volunteers to address fundamental questions in basic neuroscience, as well as in clinical populations with central nervous system disorders, including patients with focal epilepsy and patients with congenital brain lesions associated with persistent neurological deficits.

The basic neuroscience component will allow investigation of mechanisms of brain function and connectivity between eloquent cortical regions and subcortical structures. In the clinical setting, improved delineation of activation maps in eloquent brain areas and characterization of their reorganization under pathological conditions are expected to enhance personalized therapeutic decision-making and deepen our understanding of neuroplasticity mechanisms, with potential impact on clinical care pathways.

Read the detailed description

Background Magnetic Resonance Imaging (MRI) represents a unique tool for the in vivo study of the central nervous system. With the advent of ultra-high-field technologies, such as 7 Tesla (7T) MRI, the accuracy and reproducibility of studies investigating brain structures and functions-such as visual or sensorimotor systems-have increased considerably, increasingly enabling investigations at the single-subject level in addition to group-level analyses (PMID: 29205628).

This aspect is particularly relevant in clinical practice, which increasingly promotes the use of technologies that enable personalized diagnostic and therapeutic approaches in neuroscience. Such approaches integrate structural brain information with functional, molecular, and genetic aspects (PMID: 27613521, 35021279, 36870920).

Compared with clinical field strength systems (up to 3 Tesla), 7T MRI provides a substantial gain in signal-to-noise ratio (SNR), which can be exploited to improve image quality by enhancing contrast and/or spatial and temporal resolution.

Over the last years, 7T MRI has confirmed these advantages in structural neuroimaging, for example by identifying epileptogenic malformations not visible on conventional neuroimaging (PMID: 26778405) and morphological markers of highly epileptogenic areas (PMID: 31727747).

In functional MRI (fMRI) studies, ultra-high-field MRI has enabled segmentation of subcortical structures to reveal their selectivity to specific external stimuli, exploration of the functional organization of eloquent cortical areas, investigation of the cortex at the mesoscopic (submillimetric) scale-revealing cortical columns and laminar profiles-and characterization of cortico-subcortical functional connectivity (PMID: 35384840, 34111403).

In the clinical setting, particularly in acquired pre- or perinatal brain lesions, the use of 7T has been shown to provide benefits in characterizing functional organization compared with conventional clinical MRI systems (PMID: 30595689).

These premises support the hypothesis that ultra-high-field MRI may contribute to clarifying the pathophysiological mechanisms underlying the functional organization of malformed or lesioned human cerebral cortex, with two important potential translational implications:

To investigate connectivity between epileptogenic cortical areas and subcortical structures, which appears crucial for assessing the residual functional capacity of altered cortex and its role in managing synchronized subcortical electrical activity.

To explore cortical reorganization of eloquent areas following brain lesions, in order to better understand mechanisms of neuroplasticity.

Selected patients with drug-resistant epilepsy may benefit from surgical treatment involving resection of the epileptogenic zone. Current standards for pre-surgical assessment require a multimodal approach to accurately identify the epileptogenic zone and define its functional properties (PMID: 24099054). However, when the epileptogenic area overlaps with eloquent cortex, invasive stereo-EEG techniques are often required.

In addition to resection, epilepsy surgery provides the opportunity to perform histological studies on the resected tissue. Specific genetic and molecular alterations underlying dysplastic areas (e.g., those involving the mechanistic target of rapamycin [mTOR] pathway or SLC35A2 gene variants) are associated with characteristic histological abnormalities. However, an unresolved issue concerns the possibility that histologically abnormal cells may be present without forming a mass sufficient to generate an MRI-visible dysplasia eligible for surgery (PMID: 33542949).

Although recent classification systems for cortical dysplasias integrate histological, genetic, and MRI data (PMID: 35706131), some of this information is only available post hoc and therefore cannot be considered during the critical phase of neurosurgical planning. In this context, identifying morpho-functional patterns using high spatial and temporal resolution neuroimaging techniques, such as ultra-high-field functional MRI, could facilitate pre-surgical planning, reduce the need for invasive procedures, and contribute to the implementation of personalized treatment strategies (PMID: 34145582; 34742103; 30064388).

Regarding pre- or perinatal brain lesions, it is well established that different brain structures show varying vulnerability across different stages of the pre-perinatal period. This results in distinct patterns of injury, with predominant involvement of white matter or cortical/subcortical gray matter. The topography and severity of the lesion, in turn, lead to different clinical outcomes, particularly with respect to motor or sensory deficits and the recruitment of compensatory plasticity mechanisms (PMID: 33613420; 17254004).

As in cortical malformations, in vivo knowledge of mechanisms underlying reorganization of eloquent brain functions in acquired lesions may contribute to better understanding clinical presentations and identifying personalized rehabilitation pathways based on morpho-functional characteristics of the lesion.

The current project aims to develop and evaluate novel advanced 7T functional neuroimaging methods with very high spatial and temporal resolution to investigate minimal MRI signal fluctuations. Two complementary approaches will be pursued in parallel.

The first approach will focus on improving and optimizing the quality of structural and functional images using Deep Learning (DL) techniques for image correction and acceleration, as well as magnetic field monitoring through a field camera to characterize and correct local field perturbations responsible for image distortions and artifacts.

The second approach will involve the development of novel functional neuroimaging sequences (cine-fMRI) capable of detecting signal variations at temporal resolutions approaching that of neuronal action potentials. Cine-MRI techniques have thus far been applied primarily in animal models and in two-dimensional imaging (PMID: 36227975; 36227975).

Cine-fMRI will be implemented on the 7T MRI system for whole-brain studies. This technique enables dynamic imaging based on the assumption of repeated signal behavior following a specific trigger, such as an external or internal stimulus in functional MRI. Such stimuli may include neuronal events elicited externally or generated internally, such as epileptogenic activity.

Because these neuronal events are unpredictable, pseudo-random spatial encoding is required for retrospective data sorting and reconstruction into consistent images for subsequent processing.

For data acquisition, ZTE and Looping Star sequences will be explored, as both are compatible with the cine-fMRI approach. ZTE is a 3D sequence with spiral sampling that enables detection of potential direct functional fluctuations (i.e., not dependent on the BOLD effect as in conventional fMRI sequences). Looping Star is based on a multi-gradient echo sequence that allows pseudo-random data sampling with conventional T2*-weighted BOLD contrast.

After validation and optimization in phantoms and healthy volunteers, these techniques will be applied in functional studies in both basic neuroscience and two clinical populations: patients with drug-resistant epilepsy who are candidates for epilepsy surgery, and patients with acquired brain lesions.

The study will be structured into four Work Packages (WPs). WP1 and WP2 will focus on the technological development of novel processing techniques and imaging sequences for brain imaging. These two WPs will operate in close interaction, continuously informing each other and exchanging results bidirectionally throughout the project.

WP1 - Development and implementation of state-of-the-art image correction approaches. IMAGO7 and IRCCS Stella Maris, in collaboration with GEHC and THI, will develop and implement on the 7T MRI scanner new methods to enhance image quality based on: a) Deep learning (DL) algorithms to accelerate acquisition, reduce noise, and mitigate subject motion effects; b) Correction of geometric distortions through offline monitoring of local magnetic field inhomogeneities using a dynamic field camera, a device capable of directly recording the magnetic field during pulse sequences and simulating the presence of the subject without the subject being physically inside the magnet.

WP2 - Development and implementation of cine-fMRI sequences. GEHC and THI, in collaboration with IMAGO7, will lead WP2, which will focus on the development, implementation, and optimization of innovative cine-fMRI sequences on the 7T MRI scanner.

WP3 - Implementation of UHF-MRI techniques for Neuroscience. WP3 and WP4 will provide data to support and validate the implementations developed in WP1 and WP2 through their application in basic neuroscience and clinical studies. Activities within WP3, conducted in collaboration between the University of Pisa, IRCCS Stella Maris, and IMAGO7, will involve translating the newly developed functional neuroimaging methods into advanced neuroscience applications, including both task-related studies and investigations of cortico-cortical and cortico-subcortical connectivity.

WP4 - Validation and clinical translation of advanced 7T MRI methods in subjects with epilepsy or malformed/lesioned brain areas. AOU Meyer IRCCS, together with IRCCS Stella Maris and the University of Pisa, will conduct WP4. This WP will focus on the clinical application of the advanced fMRI techniques developed in WP1 and WP2 for: non-invasive localization of cortical responses, characterization of epileptogenic areas, genotype-phenotype correlations.

The application of the techniques developed in WP1 and WP2 across two substantially different contexts-basic neuroscience studies in highly cooperative healthy volunteers and clinical pediatric populations, where intrinsic image noise may be considerable-is essential to evaluate the robustness, versatility, and added value of these methods under markedly different experimental conditions.

Being tested
Functional neuroimaging
Keywords
epilepsy, 7T MRI, functional MRI, brain lesion, ultra-high field MRI
Medical subject headings
Nervous System Diseases, Epilepsy, Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Functional neuroimagingDiagnostic test

    Novel advanced method based on Ultra High Field-MRI for personalised functional neuroimaging by depicting tiny neuronal MR signal fluctuations at high spatial and temporal resolution. Two approaches will be investigated:

    1. Enhanced image quality for both structural and functional MRI through: a) DL-based denoising and sharpening reconstruction (arXiv:2008.06559) developed, tested and optimized for functional and connectivity studies; b) anti-aliasing DL reconstruction techniques (PMID: 31247254) implemented to achieve higher spatial and temporal resolution with respect to the current state of the art; c) field monitoring using the field camera developed and implemented to correct several dynamic field disturbances that result in image distortions and artifacts (PMID: 28077303).
    2. Development of a novel, non-invasive, 3D whole-brain, direct functional neuroimaging method, with unprecedented sensitivity in order to resolve tiny neuronal MR signal fluctuations
Study groups in NCT07865546
Study groupRoleWhat they receive
Deep-Learning to achieve higher spatial and temporal resolution for functional neuroimagingExperimentalThe intervention consist of the execution of the 7T MRI functional study of eloquent brain areas (including at least one among visual, sensorimotor or language function). No further visit following the MRI study will be scheduled for any participant. Each MRI study requires approximately 2 hours, including preparation. For a subgroup of volunteer subjects, two MRIs will be performed approximately two hours apart, before and after a specific research procedure (monocular deprivation) which serves to quantify plasticity of the visual system. For each volunteer, a total time commitment of approximately 5 consecutive hours is expected.
Receives: Diagnostic Test: Functional neuroimaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Spatial Resolution of Acquired Images

    • Comparison of spatial resolution (voxel size in mm) of images acquired using the different implemented techniques

    Measured: 0-36 months

  2. Temporal Resolution of Acquired Images

    • Comparison of temporal resolution (in seconds) of images acquired using the different implemented techniques

    Measured: 0-36 months

Secondary outcomes (3)
  1. Image Signal Quality Across Imaging Techniques

    • Evaluation of signal-to-noise ratio (SNR) obtained with the implemented techniques, including comparison of images before and after the application of noise correction algorithms;

    Measured: 0-36 months

  2. Image Noise Across Imaging Techniques

    • Evaluation of contrast-to-noise ratio (CNR) in images obtained with the implemented techniques, including comparison of images before and after the application of noise correction algorithms;

    Measured: 0-36 months

  3. Artifacts Across Imaging Techniques

    • Evaluation of artifacts types in images obtained with the implemented techniques, including comparison of images before and after the application of noise correction algorithms;

    Measured: 0-36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2026
  2. Study start16 Oct 2024
  3. Primary completion16 Oct 2027 (estimated)
  4. Study completion16 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07865546
Sponsor's protocol ID
AURORA-2024
Other IDs
Aurora-2024
Acronym
AURORA
Status last verified
Oct 2026
First submitted
30 Mar 2026
Last updated
8 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Voets NL, Adcock JE, Flitney DE, Behrens TE, Hart Y, Stacey R, Carpenter K, Matthews PM. Distinct right frontal lobe activation in language processing following left hemisphere injury. Brain. 2006 Mar;129(Pt 3):754-66. doi: 10.1093/brain/awh679. Epub 2005 Nov 9.

    PubMed 16280351
  • Holloway V, Gadian DG, Vargha-Khadem F, Porter DA, Boyd SG, Connelly A. The reorganization of sensorimotor function in children after hemispherectomy. A functional MRI and somatosensory evoked potential study. Brain. 2000 Dec;123 Pt 12:2432-44. doi: 10.1093/brain/123.12.2432.

    PubMed 11099446
  • Yogarajah M, Focke NK, Bonelli SB, Thompson P, Vollmar C, McEvoy AW, Alexander DC, Symms MR, Koepp MJ, Duncan JS. The structural plasticity of white matter networks following anterior temporal lobe resection. Brain. 2010 Aug;133(Pt 8):2348-64. doi: 10.1093/brain/awq175.

    PubMed 20826432
  • Pataraia E, Billingsley-Marshall RL, Castillo EM, Breier JI, Simos PG, Sarkari S, Fitzgerald M, Clear T, Papanicolaou AC. Organization of receptive language-specific cortex before and after left temporal lobectomy. Neurology. 2005 Feb 8;64(3):481-7. doi: 10.1212/01.WNL.0000150900.71773.E6.

    PubMed 15699379
  • Hertz-Pannier L, Chiron C, Jambaque I, Renaux-Kieffer V, Van de Moortele PF, Delalande O, Fohlen M, Brunelle F, Le Bihan D. Late plasticity for language in a child's non-dominant hemisphere: a pre- and post-surgery fMRI study. Brain. 2002 Feb;125(Pt 2):361-72. doi: 10.1093/brain/awf020.

    PubMed 11844736
  • Kawamura M, Tamada D, Funayama S, Kromrey ML, Ichikawa S, Onishi H, Motosugi U. Accelerated Acquisition of High-resolution Diffusion-weighted Imaging of the Brain with a Multi-shot Echo-planar Sequence: Deep-learning-based Denoising. Magn Reson Med Sci. 2021 Mar 1;20(1):99-105. doi: 10.2463/mrms.tn.2019-0081. Epub 2020 Mar 6.

    PubMed 32147643
  • Moeller S, Pisharady PK, Ramanna S, Lenglet C, Wu X, Dowdle L, Yacoub E, Ugurbil K, Akcakaya M. NOise reduction with DIstribution Corrected (NORDIC) PCA in dMRI with complex-valued parameter-free locally low-rank processing. Neuroimage. 2021 Feb 1;226:117539. doi: 10.1016/j.neuroimage.2020.117539. Epub 2020 Nov 10.

    PubMed 33186723
  • Bash S, Wang L, Airriess C, Zaharchuk G, Gong E, Shankaranarayanan A, Tanenbaum LN. Deep Learning Enables 60% Accelerated Volumetric Brain MRI While Preserving Quantitative Performance: A Prospective, Multicenter, Multireader Trial. AJNR Am J Neuroradiol. 2021 Dec;42(12):2130-2137. doi: 10.3174/ajnr.A7358. Epub 2021 Nov 25.

    PubMed 34824098
  • Pirkl CM, Nunez-Gonzalez L, Kofler F, Endt S, Grundl L, Golbabaee M, Gomez PA, Cencini M, Buonincontri G, Schulte RF, Smits M, Wiestler B, Menze BH, Menzel MI, Hernandez-Tamames JA. Accelerated 3D whole-brain T1, T2, and proton density mapping: feasibility for clinical glioma MR imaging. Neuroradiology. 2021 Nov;63(11):1831-1851. doi: 10.1007/s00234-021-02703-0. Epub 2021 Apr 9.

    PubMed 33835238
  • Ma R, Akcakaya M, Moeller S, Auerbach E, Ugurbil K, Van de Moortele PF. A field-monitoring-based approach for correcting eddy-current-induced artifacts of up to the 2nd spatial order in human-connectome-project-style multiband diffusion MRI experiment at 7T: A pilot study. Neuroimage. 2020 Aug 1;216:116861. doi: 10.1016/j.neuroimage.2020.116861. Epub 2020 Apr 16.

    PubMed 32305565
  • Vannesjo SJ, Wilm BJ, Duerst Y, Gross S, Brunner DO, Dietrich BE, Schmid T, Barmet C, Pruessmann KP. Retrospective correction of physiological field fluctuations in high-field brain MRI using concurrent field monitoring. Magn Reson Med. 2015 May;73(5):1833-43. doi: 10.1002/mrm.25303. Epub 2014 Jun 5.

    PubMed 24903278
  • Vannesjo SJ, Duerst Y, Vionnet L, Dietrich BE, Pavan M, Gross S, Barmet C, Pruessmann KP. Gradient and shim pre-emphasis by inversion of a linear time-invariant system model. Magn Reson Med. 2017 Oct;78(4):1607-1622. doi: 10.1002/mrm.26531. Epub 2016 Oct 31.

    PubMed 27797105
  • Vannesjo SJ, Graedel NN, Kasper L, Gross S, Busch J, Haeberlin M, Barmet C, Pruessmann KP. Image reconstruction using a gradient impulse response model for trajectory prediction. Magn Reson Med. 2016 Jul;76(1):45-58. doi: 10.1002/mrm.25841. Epub 2015 Jul 27.

    PubMed 26211410
  • Fiori S, Biagi L, Cecchi P, Cioni G, Beani E, Tosetti M, Cosottini M, Guzzetta A. Potentials of Ultrahigh-Field MRI for the Study of Somatosensory Reorganization in Congenital Hemiplegia. Neural Plast. 2018 Nov 25;2018:8472807. doi: 10.1155/2018/8472807. eCollection 2018.

    PubMed 30595689
  • Benedetto A, Binda P, Costagli M, Tosetti M, Morrone MC. Predictive visuo-motor communication through neural oscillations. Curr Biol. 2021 Aug 9;31(15):3401-3408.e4. doi: 10.1016/j.cub.2021.05.026. Epub 2021 Jun 9.

    PubMed 34111403

Questions about this trial

What is this clinical trial studying?

A study testing Functional neuroimaging in people with Neurological Disorders and Neuroscience, run by Imago 7 Fondazione di Ricerca onlus at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact gilda gallucci (0039 050886233, gilda.gallucci@fsm.unipi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Spatial Resolution of Acquired Images (time frame: 0-36 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07865546, which also lists 36 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in